Lincoln National Corp’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,016
| Closed | -$1.24M | – | 512 |
|
|
2024
Q1 | $1.24M | Buy |
9,016
+783
| +10% | +$107K | 0.02% | 452 |
|
|
2023
Q4 | $1.12M | Sell |
8,233
-1,398
| -15% | -$190K | 0.02% | 434 |
|
|
2023
Q3 | $1.18M | Buy |
9,631
+394
| +4% | +$48.2K | 0.02% | 368 |
|
|
2023
Q2 | $1.17M | Buy |
9,237
+129
| +1% | +$16.4K | 0.02% | 368 |
|
|
2023
Q1 | $1.18M | Buy |
9,108
+21
| +0.2% | +$2.71K | 0.02% | 345 |
|
|
2022
Q4 | $1.19M | Buy |
9,087
+2,780
| +44% | +$365K | 0.03% | 318 |
|
|
2022
Q3 | $737K | Sell |
6,307
-108
| -2% | -$12.6K | 0.02% | 393 |
|
|
2022
Q2 | $754K | Sell |
6,415
-1,832
| -22% | -$215K | 0.02% | 394 |
|
|
2022
Q1 | $1.08M | Buy |
8,247
+1,075
| +15% | +$140K | 0.02% | 343 |
|
|
2021
Q4 | $1.1M | Buy |
7,172
+326
| +5% | +$49.8K | 0.02% | 330 |
|
|
2021
Q3 | $1.11M | Sell |
6,846
-284
| -4% | -$45.9K | 0.02% | 308 |
|
|
2021
Q2 | $1.17M | Buy |
7,130
+244
| +4% | +$39.9K | 0.03% | 281 |
|
|
2021
Q1 | $1.04M | Buy |
6,886
+158
| +2% | +$23.8K | 0.03% | 286 |
|
|
2020
Q4 | $1.02M | Sell |
6,728
-52
| -0.8% | -$7.88K | 0.03% | 277 |
|
|
2020
Q3 | $918K | Sell |
6,780
-1,392
| -17% | -$188K | 0.03% | 267 |
|
|
2020
Q2 | $1.12M | Buy |
8,172
+1,394
| +21% | +$191K | 0.04% | 224 |
|
|
2020
Q1 | $730K | Sell |
6,778
-211
| -3% | -$22.7K | 0.03% | 266 |
|
|
2019
Q4 | $842K | Buy |
6,989
+1,611
| +30% | +$194K | 0.03% | 293 |
|
|
2019
Q3 | $535K | Buy |
5,378
+441
| +9% | +$43.9K | 0.02% | 330 |
|
|
2019
Q2 | $538K | Buy |
4,937
+2,183
| +79% | +$238K | 0.02% | 308 |
|
|
2019
Q1 | $308K | Buy |
2,754
+270
| +11% | +$30.2K | 0.01% | 384 |
|
|
2018
Q4 | $239K | Buy |
2,484
+706
| +40% | +$67.9K | 0.01% | 396 |
|
|
2018
Q3 | $217K | Buy |
+1,778
| New | +$217K | 0.01% | 439 |
|
|
2018
Q1 | – | Sell |
-4,755
| Closed | -$508K | – | 549 |
|
|
2017
Q4 | $508K | Buy |
4,755
+2,535
| +114% | +$271K | 0.02% | 366 |
|
|
2017
Q3 | $246K | Buy |
2,220
+150
| +7% | +$16.6K | 0.01% | 353 |
|
|
2017
Q2 | $214K | Buy |
+2,070
| New | +$214K | 0.01% | 322 |
|